Lindsey E. Montefiori
0000-0003-2342-6349
Publication & Citation Trends
Publications
0 total
POSTER: ALL-594 Preclinical Assessment of Dual FLT3 and BCL-2 Inhibition in Lineage Ambiguous Leukemia
Cited by 1
Semantic Scholar
S102: COMPREHENSIVE GENOME CHARACTERIZATION REVEALS NEW SUBTYPES AND MECHANISMS OF ONCOGENE DEREGULATION IN CHILDHOOD T-ALL OA
Cited by 1
Semantic Scholar
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia. OA
Cited by 33
Semantic Scholar
Comprehensive Genome Characterization of Childhood T-ALL Links Oncogene Activation Mechanism and Subtypes to Prognosis OA
Cited by 3
Semantic Scholar
ALL-090 Highly Effective Combination of FLT3 and BCL2 Inhibitors in a Preclinical Model of Lineage Ambiguous Leukemia.
Cited by 1
Semantic Scholar
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms OA
Cited by 52
Semantic Scholar
Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage. OA
Cited by 16
Semantic Scholar
Research Topics
Acute Lymphoblastic Leukemia research
(59)
Acute Myeloid Leukemia Research
(18)
Chronic Lymphocytic Leukemia Research
(10)
Genomics and Chromatin Dynamics
(8)
Chronic Myeloid Leukemia Treatments
(6)
Affiliations
National Institutes of Health
St. Jude Children's Research Hospital
University of California, San Diego
University of Chicago
National Institute on Aging